Angelika Bátorová, Vladimír Cupaník, Denisa Jankovičová, Tatiana Prigancová, Anna Kyselová
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is an important cause of morbidity in pregnant women in developed countries. Pulmonary embolism is also the leading cause of non-obstetrical maternal mortality. The risk of VTE is 4-6 times higher in pregnant women compared to non-pregnant women due to physiological and anatomical changes accompanying pregnancy. This risk is further increased in the presence of factors related to the constitution and co-morbidities of the pregnant woman. In the last decade, several guidelines have been developed, which are used to estimate the individual risk of VTE in pregnant women, but also in decision making in the prevention and treatment of VTE during pregnancy and after en_delivery. The implementation of standardized management in the developed countries has led to a significant reduction in maternal morbidity and mortality due to venous thromboembolism.